To study the effectiveness of Siddha treatment in patients with psoriasis with respect to gene (HLA-Cw6) and inflammatory mediators
Not Applicable
- Conditions
- Health Condition 1: L400- Psoriasis vulgaris
- Registration Number
- CTRI/2020/02/023597
- Lead Sponsor
- Directorate of Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients of both sexes and age above 18 years, patients with moderate to severe psoriasis (PASI score >10), patients with no systemic therapy for past four weeks or topical therapy for past two weeks
Exclusion Criteria
Pregnant and lactating woman, coexisting eczema or lichen planus, patients on any systemic drugs known to exacerbate psoriasis, patients who are on any other treatment for psoriasis.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method